Intelligent Ocular Therapy Systems with Synergistic Combinations

The present inventive concept integrates patented ocular delivery systems with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to create a new generation of personalized, data-driven, and highly effective treatments for ocular diseases.

The original patent described innovative systems and methods for accessing Schlemm's canal in an eye and delivering a fluid composition therein. However, the original patent's methods and systems lacked the ability to leverage advanced technologies to enhance treatment outcomes, monitor patient data, and provide personalized therapy. The present inventive concept addresses these limitations by combining the patented ocular delivery systems with synergistic technologies to create a more powerful, data-driven, and personalized system.

The inventive concept disclosed herein combines the patented ocular delivery systems with AI-based image processing modules to guide the fluid delivery system, IoT-enabled wearable sensors to monitor intraocular pressure, blockchain-based data storage units to track treatment outcomes, nanomaterial-based coatings to enhance tissue disruption, machine learning algorithms to predict optimal treatment parameters, and genetic testing modules to identify genetic markers associated with glaucoma. These synergistic combinations enable real-time monitoring of treatment outcomes, personalized therapy, and data-driven decision-making.

The present inventive concept's novelty lies in the integration of patented ocular delivery systems with distinct technologies like AI, IoT, blockchain, and nanomaterials to create a new, more powerful system. The inventive step resides in the unexpected synergy between these technologies, which enables personalized, data-driven, and highly effective treatments for ocular diseases.

Alternative embodiments of the inventive concept may include the use of other advanced technologies like computer vision, robotics, or 3D printing to further enhance treatment outcomes. Variations may also include the application of the inventive concept to other ocular diseases or conditions beyond glaucoma.

The inventive concept has significant commercial potential in the ophthalmology and healthcare industries, particularly in the areas of personalized medicine, data analytics, and digital health. The target market includes ophthalmologists, optometrists, and patients seeking advanced, data-driven treatments for ocular diseases.